BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Rosiglitazone
,
rs2300478
,
NEUROG3
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
al 108
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
A Genome-wide association study of bone mineral density - Kung et al
Neutrophil response to A. phagocytophilum and S. aureus infection
Effects of spaceflight on murine skeletal muscle gene expression
Pediatric acute lymphoblastic leukemia subtypes
Bone marrow gene expression associated with relapse in childhood acute lymphoblastic leukemia (ALL)
Explore Curated Studies Results
Literature
Most Relevant Literature
A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerab…
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in sc…
Addressing Alzheimer's disease tangles: from NAP to AL-108.
AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprote…
Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Scl…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Multicenter Study of NAP (AL-108) in Schizophrenia
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacit…
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects Wi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ